ARTICLE
|
doi:10.20944/preprints202402.0495.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
diabetes; sotagliflozin; empagliflozin; sglt1; sglt2
Online: 8 February 2024 (07:37:28 CET)
ARTICLE
|
doi:10.20944/preprints202306.0014.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
SGLT2 inhibition; empagliflozin; heart failure; interleukin 6
Online: 1 June 2023 (03:33:38 CEST)
ARTICLE
|
doi:10.20944/preprints202205.0346.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
β-adrenoceptor; diabetes; empagliflozin; heart; pressure-volume loop analysis
Online: 25 May 2022 (09:59:26 CEST)
REVIEW
|
doi:10.20944/preprints202204.0202.v1
Subject:
Medicine And Pharmacology,
Endocrinology And Metabolism
Keywords:
Metabolic syndrome; SGLT2 inhibitors; Dapagliflozin; Empagliflozin; Canagliflozin; Translational modeling
Online: 21 April 2022 (10:12:04 CEST)
ARTICLE
|
doi:10.20944/preprints202402.1288.v2
Subject:
Medicine And Pharmacology,
Endocrinology And Metabolism
Keywords:
SGLT2 Inhibitors; Empagliflozin; Renal fibrosis; Connective tissue growth factor; Epithelial-mesenchymal transition
Online: 23 February 2024 (13:25:01 CET)
ARTICLE
|
doi:10.20944/preprints202304.1063.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
empagliflozin; vascular calcification; AMP-activated protein kinase; nuclear factor erythroid-2-related factor; heme oxygenase 1; chronic kidney disease
Online: 27 April 2023 (09:35:25 CEST)